Simplex Trading’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.19K Buy
+1,500
New +$3.57K ﹤0.01% 8151
2025
Q4
Sell
-2,500
Closed -$9K 8558
2025
Q3
$9K Buy
+2,500
New +$7.31K ﹤0.01% 7942
2025
Q2
Sell
-700
Closed -$1K 8631
2025
Q1
$1K Sell
700
-5,700
-89% -$12K ﹤0.01% 8150
2024
Q4
$13K Sell
6,400
-149,500
-96% -$428K ﹤0.01% 6986
2024
Q3
$678K Buy
+155,900
New +$848K ﹤0.01% 3278
2024
Q1
Sell
-600
Closed -$1K 8840
2023
Q4
$1K Buy
+600
New +$1.41K ﹤0.01% 8434
2023
Q3
Sell
-13,200
Closed -$66K 8670
2023
Q2
$66K Buy
+13,200
New +$27K ﹤0.01% 5532
2022
Q4
Sell
-266,100
Closed -$449K 9204
2022
Q3
$449K Buy
266,100
+79,800
+43% +$246K ﹤0.01% 3584
2022
Q2
$458K Buy
186,300
+185,800
+37,160% +$432K ﹤0.01% 3538
2022
Q1
$1K Sell
500
-400
-44% -$1.46K ﹤0.01% 10030
2021
Q4
$4K Sell
900
-3,200
-78% -$22.4K ﹤0.01% 9640
2021
Q3
$50K Hold
4,100
﹤0.01% 7502
2021
Q2
$49K Buy
+4,100
New +$81.1K ﹤0.01% 7654

Other funds holding BDTX

Simplex Trading's BDTX Position: Q3 2025 in Review

Simplex Trading sold out of Black Diamond Therapeutics (BDTX) in Q3 2025, closing a stake of 2,186 shares — an estimated $6.39K sold.

Simplex Trading first reported a position in BDTX in Q1 2021 and held it in 12 quarters. The position peaked at $98K in Q2 2024. 91 funds tracked by Wall St. Rank hold BDTX as of Q3 2025.

  • Simplex Trading reported no remaining Black Diamond Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,186 Black Diamond Therapeutics shares in Q3 2025, an estimated $6.39K.
  • Simplex Trading first reported a position in Black Diamond Therapeutics in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Black Diamond Therapeutics position peaked at $98K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.